Drupal.behaviors.print = function(context) {window.print();window.close();}>
Swift Nets $750K Investment from Michigan Accelerator Fund I
January 17, 2013
Swift Nets $750K Investment from Michigan Accelerator Fund I
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Swift Biosciences Licenses Primer Tech to Vela Diagnostics
December 6, 2012 / PCR Insider
VelaDx Licenses Swift Bio's Primer Technology for PCR-based Dx
December 3, 2012 / GenomeWeb Daily News
Swift Biosciences Launches BRAF Mutation Assay; Tacks on $2.4M to Series A Financing Round
February 23, 2012 / PCR Insider
Abbott, GSK Add New Biomarker to Cancer Immunotherapy Companion Dx Agreement
December 1, 2011 / PCR Insider
DermTech Replicates Melanoma Test's Microarray Results on OpenArray Tech, Plans Further Validation
November 17, 2011 / PCR Insider